Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Sleeping Beauty technique helps identify genes responsible for NAFLD-associated liver cancer

Sleeping Beauty technique helps identify genes responsible for NAFLD-associated liver cancer

One-time universal screening recommended to tackle increase in hepatitis C

One-time universal screening recommended to tackle increase in hepatitis C

Researchers use CRISPR-Cas9 to prevent congenital disease in utero

Researchers use CRISPR-Cas9 to prevent congenital disease in utero

New report provides overview of cancer risk among U.S. Hispanics/Latinos

New report provides overview of cancer risk among U.S. Hispanics/Latinos

Cancer risk due to lifestyle and environmental factors can be prevented

Cancer risk due to lifestyle and environmental factors can be prevented

Researchers decipher antitumor mechanism of Amazonian plant in human cancer cells

Researchers decipher antitumor mechanism of Amazonian plant in human cancer cells

VRK1 protein may enable cancer cells to colonize new areas of the body during metastasis

VRK1 protein may enable cancer cells to colonize new areas of the body during metastasis

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

UK and European research collaborations receive vote of confidence by three major cancer charities

UK and European research collaborations receive vote of confidence by three major cancer charities

Cellular environment affects type of tumor development

Cellular environment affects type of tumor development

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Novel approaches for personalized risk prognosis and individualized treatment of NAFLD

Novel approaches for personalized risk prognosis and individualized treatment of NAFLD

Researchers discover mechanism that steers growth of cancer cells in melanoma and liver cancer

Researchers discover mechanism that steers growth of cancer cells in melanoma and liver cancer

Study suggests new strategies for using cell metabolism to treat cancer

Study suggests new strategies for using cell metabolism to treat cancer

Newly discovered target may prevent progression of liver injury to cancer

Newly discovered target may prevent progression of liver injury to cancer

Surgeons test new device that keeps the liver warm and circulates blood during transport

Surgeons test new device that keeps the liver warm and circulates blood during transport

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Cocktail of nanoparticles and contaminants may have harmful effects on human cells

Cocktail of nanoparticles and contaminants may have harmful effects on human cells

Increasing dietary protein may lower risk of diabetes in people with NAFLD

Increasing dietary protein may lower risk of diabetes in people with NAFLD